505 related articles for article (PubMed ID: 28877074)
1. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
[TBL] [Abstract][Full Text] [Related]
2. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
3. Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma.
Kim HJ; Kim HK; Park G; Min SK; Cha HJ; Lee H; Choi SJ; Na HY; Choe JY; Kim JE
Diagn Pathol; 2019 Dec; 14(1):133. PubMed ID: 31831043
[TBL] [Abstract][Full Text] [Related]
4. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.
Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ
Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666
[TBL] [Abstract][Full Text] [Related]
5. Dendritic Cell Markers and PD-L1 are Expressed in Mediastinal Gray Zone Lymphoma.
Pelland K; Mathews S; Kamath A; Cohen P; Hudnall SD; Cotta CV; Xu ML
Appl Immunohistochem Mol Morphol; 2018; 26(10):e101-e106. PubMed ID: 29189264
[TBL] [Abstract][Full Text] [Related]
6. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.
Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733
[TBL] [Abstract][Full Text] [Related]
7. Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?
Grant C; Dunleavy K; Eberle FC; Pittaluga S; Wilson WH; Jaffe ES
Curr Hematol Malig Rep; 2011 Sep; 6(3):157-63. PubMed ID: 21590365
[TBL] [Abstract][Full Text] [Related]
8. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
Churchill HR; Roncador G; Warnke RA; Natkunam Y
Hum Pathol; 2010 Dec; 41(12):1726-34. PubMed ID: 20825974
[TBL] [Abstract][Full Text] [Related]
9. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
[TBL] [Abstract][Full Text] [Related]
10. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
Tian X; Xu J; Dorfman DM
Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
[TBL] [Abstract][Full Text] [Related]
11. Shades of gray between large B-cell lymphomas and Hodgkin lymphomas: differential diagnosis and biological implications.
Harris NL
Mod Pathol; 2013 Jan; 26 Suppl 1():S57-70. PubMed ID: 23281436
[TBL] [Abstract][Full Text] [Related]
12. Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities.
Tousseyn TA; King RL; Fend F; Feldman AL; Brousset P; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):207-226. PubMed ID: 36274093
[TBL] [Abstract][Full Text] [Related]
13. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
Wu D; Thomas A; Fromm JR
Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
[TBL] [Abstract][Full Text] [Related]
14. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
Traverse-Glehen A; Pittaluga S; Gaulard P; Sorbara L; Alonso MA; Raffeld M; Jaffe ES
Am J Surg Pathol; 2005 Nov; 29(11):1411-21. PubMed ID: 16224207
[TBL] [Abstract][Full Text] [Related]
15. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
Hartmann S; Döring C; Vucic E; Chan FC; Ennishi D; Tousseyn T; de Wolf-Peeters C; Perner S; Wlodarska I; Steidl C; Gascoyne RD; Hansmann ML
Br J Haematol; 2015 May; 169(3):415-22. PubMed ID: 25644177
[TBL] [Abstract][Full Text] [Related]
16. Geographic Variability of Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Xia D; Sayed S; Moloo Z; Gakinya SM; Mutuiri A; Wawire J; Okiro P; Courville EL; Hasserjian RP; Sohani AR
Am J Clin Pathol; 2022 Feb; 157(2):231-243. PubMed ID: 34542569
[TBL] [Abstract][Full Text] [Related]
17. American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma.
O'Malley DP; Dogan A; Fedoriw Y; Medeiros LJ; Ok CY; Salama ME
Ann Diagn Pathol; 2019 Apr; 39():105-110. PubMed ID: 30802809
[TBL] [Abstract][Full Text] [Related]
18. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.
Boudová L; Torlakovic E; Delabie J; Reimer P; Pfistner B; Wiedenmann S; Diehl V; Müller-Hermelink HK; Rüdiger T
Blood; 2003 Nov; 102(10):3753-8. PubMed ID: 12881319
[TBL] [Abstract][Full Text] [Related]
19. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma.
Ravindran A; Kurtin PJ; King RL; Yuan J; Feldman AL; Rech KL; McPhail ED; Parikh SA; Ding W; Shi M
Hum Pathol; 2022 Jul; 125():2-10. PubMed ID: 35421421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
